Filing Details
- Accession Number:
- 0001181431-10-011643
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-02-24 12:00:00
- Reporting Period:
- 2010-02-22
- Filing Date:
- 2010-02-24
- Accepted Time:
- 2010-02-24 16:59:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1086939 | Novamed Inc | NOVA | Services-Misc Health & Allied Services, Nec (8090) | 364116193 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1205530 | Md H Scott Kirk | C/O Kirk Eye Center 7427 Lake Street River Forest IL 60305 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-02-22 | 2,600 | $4.25 | 444,541 | No | 4 | S | Indirect | See Footnote 1 |
Common Stock | Disposition | 2010-02-23 | 16,100 | $4.12 | 428,441 | No | 4 | S | Indirect | See Footnote 1 |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnote 1 |
No | 4 | S | Indirect | See Footnote 1 |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 134,595 | Direct | |
Common Stock | 662,660 | Indirect | See Footnote 2 |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | $0.83 | 2012-05-23 | 100,000 | 0 | Direct | |
Common Stock | Stock Option (right to buy) | $4.45 | 2014-03-16 | 25,000 | 0 | Direct | |
Common Stock | Stock Option (right to buy) | $5.96 | 2015-06-16 | 15,000 | 0 | Direct | |
Common Stock | Stock Option (right to buy) | $6.87 | 2016-06-20 | 15,000 | 0 | Direct | |
Common Stock | Stock Option (right to buy) | $7.35 | 2017-02-21 | 12,000 | 0 | Direct | |
Common Stock | Stock Option (right to buy) | $2.75 | 2019-02-18 | 20,000 | 0 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2012-05-23 | 100,000 | 0 | Direct |
2014-03-16 | 25,000 | 0 | Direct |
2015-06-16 | 15,000 | 0 | Direct |
2016-06-20 | 15,000 | 0 | Direct |
2017-02-21 | 12,000 | 0 | Direct |
2019-02-18 | 20,000 | 0 | Direct |
Footnotes
- Represents shares of common stock held by Kirk Eye Center, S.C., of which Dr. Kirk is a shareholder. Dr. Kirk disclaims beneficial ownership of these shares, except to the extent of his proportionate pecuniary interest therein.
- Represents shares of common stock held by Scott Kirk Family LLC. Dr. Kirk is the manager and a member of the LLC. Dr. Kirk disclaims beneficial ownership of these shares, except to the extent of his proportionate pecuniary interest therein.
- Subject to certain restrictions, 12,500 of these options vested on 11/23/02 with the remainder vesting 2,083 per month starting on 12/23/02.
- Subject to certain restrictions, 3,125 of these options vested on 9/16/04 with the remainder vesting 520 per month starting on 10/16/04.
- Subject to certain restrictions, 1,875 of these options vested on 12/17/05, with the remainder vesting 312 per month starting on 1/17/06.
- Subject to certain restrictions, 1,875 of these options vested on 12/20/06 with the remainder vesting 312 per month starting on 1/20/07.
- Subject to certain restrictions, 1,500 of these options vested on 8/21/07 with the remainder vesting 250 per month starting 9/21/07.
- Includes 22,898 restricted shares of common stock.
- Subject to certain restrictions, 2,500 of these options vested on 8/18/09 with the remainder vesting approximately 417 per month starting on 9/18/09.
- These shares were sold in multiple transactions ranging from 4.10 to 4.14, inclusive. The reporting person undertakes to provide to NovaMed, Inc., and security holder of NovaMed, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price in the foregoing range.